Year archive

Nykode Therapeutics ASA — 2025 filings

All 67 regulatory filings released by Nykode Therapeutics ASA (NYKD) in 2025, sourced directly from the official regulator.

67 Filings

2025 Period

2025 filings (67)

Filing	Released	Lang
Financial calendar Report Publication Announcement	2025-12-30	English
Nykode Therapeutics to Present Interim Data from the VB-C-03 trial at the 10th International Congress on Innovative Approaches in Head & Neck Oncology (ICHNO) on March 20, 2026 - Attachment: 251219_IC Regulatory Filings	2025-12-19	English
Nykode Therapeutics to Present Interim Data from the VB-C-03 trial at the 10th International Congress on Innovative Approaches in Head & Neck Oncology (ICHNO) on March 20, 2026 Regulatory Filings	2025-12-19	English
Nykode Therapeutics ASA - Notice of Extraordinary General Meeting - Attachment: 251218 - NYKD - EGM notice.pdf Proxy Solicitation & Information Statement	2025-12-18	English
Nykode Therapeutics Strengthens Board with the Nomination of Dr. Barbara Krebs-Pohl as New Chair of the Board and Dr. John Beadle as Board Member - Attachment: 251218_new Board members.pdf Board/Management Information	2025-12-18	English
Nykode Therapeutics ASA - Notice of Extraordinary General Meeting AGM Information	2025-12-18	English
Nykode Therapeutics Strengthens Board with the Nomination of Dr. Barbara Krebs-Pohl as New Chair of the Board and Dr. John Beadle as Board Member Board/Management Information	2025-12-18	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider - Attachment: Attachment 251124.pdf Director's Dealing	2025-11-24	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2025-11-24	English
Nykode Therapeutics - Quarterly Report Q3 2025 - Attachment: 251124 Nykode Quarterly Report Q3 2025.pdf Interim / Quarterly Report Q3 2023	2025-11-24	English
Nykode Therapeutics - Quarterly Report Q3 2025 Report Publication Announcement	2025-11-24	English
Nykode Therapeutics – Invitation to Q3 2025 Financial Results Presentation - Attachment: 251113_Nykode Therapeutics_Q3 2025 Invitation to webcast.pdf Report Publication Announcement	2025-11-13	English
Nykode Therapeutics – Invitation to Q3 2025 Financial Results Presentation Report Publication Announcement	2025-11-13	English
Nykode Therapeutics to Present Data on the Strength of the Neoantigen Selection Method from Two Clinical Trials at the Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting - Attachment: 251 Regulatory Filings	2025-11-05	English
Nykode Therapeutics to Present Data on the Strength of the Neoantigen Selection Method from Two Clinical Trials at the Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting Regulatory Filings	2025-11-05	English
Nykode Therapeutics Strengthens Intellectual Property Portfolio with New U.S. Patent for the Neoantigen Selection Method for VB10.NEO, Nykode’s Individualized Neoantigen Therapy - Attachment: 251104 N Regulatory Filings	2025-11-04	English
Nykode Therapeutics Strengthens Intellectual Property Portfolio with New U.S. Patent for the Neoantigen Selection Method for VB10.NEO, Nykode’s Individualized Neoantigen Therapy Regulatory Filings	2025-11-04	English
Disclosure of Large Shareholding - Nykode Therapeutics ASA - Attachment: CGC_212269179_Nykode_Therapeutics_ASA_42591_Filing.fo (1).pdf Major Shareholding Notification	2025-10-14	English
Disclosure of Large Shareholding - Nykode Therapeutics ASA - Attachment: SCWF_26102_3401_212269179_Nykode_Therapeutics_ASA_42592_Filing.fo.pdf Major Shareholding Notification	2025-10-14	English
Disclosure of Large Shareholding - Nykode Therapeutics ASA Major Shareholding Notification	2025-10-14	English
Nykode Therapeutics – Grant of Share Options - Attachment: Attachment Options 251010.pdf Director's Dealing	2025-10-10	English
Nykode Therapeutics – Grant of Share Options Remuneration Information	2025-10-10	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider - Attachment: 251010 Attachment Ubiquity.pdf Director's Dealing	2025-10-10	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2025-10-10	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider - Attachment: Attachment 251010.pdf Director's Dealing	2025-10-10	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2025-10-10	English
Financial calendar Report Publication Announcement	2025-10-09	English
Nykode Announces Updated Strategy to Increase Value for Patients and Shareholders, Prioritizing VB10.16 as the Lead Value Driver - Attachment: 250827 Nykode - Strategy Update.pdf Regulatory Filings	2025-08-27	English
Nykode Announces Updated Strategy to Increase Value for Patients and Shareholders, Prioritizing VB10.16 as the Lead Value Driver Regulatory Filings	2025-08-27	English
Nykode Therapeutics - Quarterly report Q2 2025 - Attachment: 250827 Nykode Quarterly Report Q2 2025.pdf Interim / Quarterly Report Q2 2025	2025-08-27	English
Nykode Therapeutics - Quarterly report Q2 2025 Report Publication Announcement	2025-08-27	English
Nykode Therapeutics – Invitation to Q2 2025 Financial Results Presentation and Strategy Update - Attachment: 250820_Nykode Therapeutics_Q2 2025 Invitation to webcast.pdf Report Publication Announcement	2025-08-20	English
Nykode Therapeutics – Invitation to Q2 2025 Financial Results Presentation and Strategy Update Report Publication Announcement	2025-08-20	English
Nykode Therapeutics – Grant of Share Options - Attachment: Attachment 250709.pdf Director's Dealing	2025-07-09	English
Nykode Therapeutics – Grant of Share Options Share Issue/Capital Change	2025-07-09	English
Financial calendar Report Publication Announcement	2025-07-04	English
Nykode Therapeutics - Quarterly report Q1 2025 - Attachment: 250528 Nykode Quarterly Report Q1 2025.pdf Interim / Quarterly Report Q1 2025	2025-05-28	English
Nykode Therapeutics - Quarterly report Q1 2025 Report Publication Announcement	2025-05-28	English
Nykode Therapeutics ASA - Ex-dividend NOK 1.00 today Notice of Dividend Amount	2025-05-27	English
Nykode Therapeutics – invitation to Q1 2025 financial results presentation - Attachment: 250526_Nykode Therapeutics_Q1 2025 Invitation to webcast.pdf Report Publication Announcement	2025-05-26	English
Nykode Therapeutics – invitation to Q1 2025 financial results presentation Earnings Release Q1 2025	2025-05-26	English
Nykode Therapeutics ASA - Minutes of Annual General Meeting - Attachment: 250526 - Nykode AGM minutes.pdf AGM Information	2025-05-26	English
Nykode Therapeutics ASA - Minutes of Annual General Meeting AGM Information	2025-05-26	English
Nykode Therapeutics Highlights New Data in Two Poster Presentations at the 2025 ASCO Annual Meeting Investor Presentation	2025-05-23	English
Nykode Therapeutics Highlights New Data in Two Poster Presentations at the 2025 ASCO Annual Meeting Regulatory Filings	2025-05-23	English
Nykode Therapeutics ASA - Notice of Annual General Meeting AGM Information	2025-05-05	Norwegian
Nykode Therapeutics ASA - Notice of Annual General Meeting AGM Information	2025-05-05	English
Nykode Therapeutics - Annual Report 2024 Annual Report FY 2024	2025-04-29	English
Nykode Therapeutics - Annual Report 2024 Annual Report FY 2024	2025-04-29	English
Nykode Therapeutics - Annual Report 2024 Report Publication Announcement	2025-04-29	English
Nykode Therapeutics – Key information relating to proposed cash dividend Notice of Dividend Amount	2025-04-28	English
Nykode Therapeutics ASA - Minutes of Extraordinary General Meeting AGM Information	2025-04-23	English
Nykode Therapeutics ASA - Minutes of Extraordinary General Meeting AGM Information	2025-04-23	English
Financial calendar Report Publication Announcement	2025-04-11	English
Nykode Therapeutics ASA - Notice of Extraordinary General Meeting AGM Information	2025-04-02	English
Nykode Therapeutics ASA - Notice of Extraordinary General Meeting AGM Information	2025-04-02	English
Nykode Therapeutics - Mandatory Notification of Trade by Closely Associated Party of a Primary Insider Director's Dealing	2025-03-27	English
Nykode Therapeutics - Mandatory Notification of Trade by Closely Associated Party of a Primary Insider Director's Dealing	2025-03-27	English
OSLO BØRS – TRADING RESUMPTION Regulatory Filings	2025-03-27	English
Nykode Therapeutics – resignation of Chair of the Board, Board Members, Chief Executive Officer, Chief Scientific Officer and Chief Financial Officer Board/Management Information	2025-03-27	English
OSLO BØRS - TRADING SUSPENSION Delisting Announcement	2025-03-27	English
Nykode Therapeutics Announces Preclinical Data Highlighting its Immune Tolerance Platform’s Ability to Modulate Multiple Key Immune Components in Autoimmune Disease Regulatory Filings	2025-02-27	English
Nykode Therapeutics Announces Preclinical Data Highlighting its Immune Tolerance Platform’s Ability to Modulate Multiple Key Immune Components in Autoimmune Disease Regulatory Filings	2025-02-27	English
Nykode Therapeutics - Quarterly report Q4 2024 Interim / Quarterly Report Q4 2024	2025-02-26	English
Nykode Therapeutics - Quarterly report Q4 2024 Report Publication Announcement Q4 2024	2025-02-26	English
Nykode Therapeutics – invitation to Q4 2024 financial results presentation Report Publication Announcement	2025-02-14	English
Nykode Therapeutics – invitation to Q4 2024 financial results presentation Report Publication Announcement	2025-02-14	English